Evidence map›Paper›PMID 24290756›Full record

ArticleCell reports2013

An IKKα-nucleophosmin axis utilizes inflammatory signaling to promote genome integrity.

Xiaojun Xia, Shuang Liu, Zuoxiang Xiao, Feng Zhu, Na-Young Song, Ming Zhou, Bigang Liu, Jianjun Shen, Kunio Nagashima, Timothy D Veenstra and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. The roles of IKKα in normal physiology and cancer.Cell communication and signaling : CCS · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. IKKα inactivation promotes Kras-initiated lung adenocarcinoma development through disrupting major redox regulatory pathways.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Xiaojun XiaDepartment of Nanomedicine, Houston Methodist Hospital Research Institute, Houston, TX 77030, USA.
Shuang LiuCancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21701, USA.
Zuoxiang XiaoCancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21701, USA.
Feng ZhuCancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21701, USA.
Na-Young SongCancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21701, USA.
Ming ZhouLaboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.
Bigang LiuDepartment of Molecular Carcinogenesis, The University of Texas M. D. Anderson Cancer Center, Unit 389, Smithville, TX 78957, USA.
Jianjun ShenDepartment of Molecular Carcinogenesis, The University of Texas M. D. Anderson Cancer Center, Unit 389, Smithville, TX 78957, USA.
Kunio NagashimaAdvanced Technology Program, Electron Microscopy Laboratory, SAIC-Frederick, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.
Timothy D VeenstraLaboratory of Proteomics and Analytical Technologies, SAIC-Frederick, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.
Sandra BurkettMouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21701, USA.
Mahesh DatlaCancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21701, USA.
Jami Willette-BrownCancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21701, USA.
Haifa ShenDepartment of Nanomedicine, Houston Methodist Hospital Research Institute, Houston, TX 77030, USA.
Yinling HuCancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21701, USA. Electronic address: huy2@mail.nih.gov.
National Cancer Institute · USCenter for Cancer Research · USHouston Methodist · USScience Applications International Corporation (United States) · USThe University of Texas MD Anderson Cancer Center · USCancer Genetics (United States) · USFrederick National Laboratory for Cancer Research · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Functions of IKK&945; in Skin Homeostasis and Skin TumorigenesisZIABC011212 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HU, YINLING · 2009 to 2025
$11.0M
Role of IKK alpha in lung squamous cell carcinoma developmentZIABC011391 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HU, YINLING · 2011 to 2025
$9.1M
IkB Kinase alpha (IKKalpha): Role in Skin CarcinogenesisR01CA102510 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HU, YINLING · 2003 to 2007
$1.7M
Intramural NIH HHS ZIA BC011212Intramural NIH HHS ZIA BC011391NCI NIH HHS CA-102510NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA102510
6 · The paper itself

Abstract

The inflammatory microenvironment promotes skin tumorigenesis. However, the mechanisms by which cells protect themselves from inflammatory signals are unknown. Downregulation of IKKα promotes skin tumor progression from papillomas to squamous cell carcinomas, which is frequently accompanied by genomic instability, including aneuploid chromosomes and extra centrosomes. In this study, we found that IKKα promoted oligomerization of nucleophosmin (NPM), a negative centrosome duplication regulator, which further enhanced NPM and centrosome association, inhibited centrosome amplification, and maintained genome integrity. Levels of NPM hexamers and IKKα were conversely associated with skin tumor progression. Importantly, proinflammatory cytokine-induced IKKα activation promoted the formation of NPM oligomers and reduced centrosome numbers in mouse and human cells, whereas kinase-dead IKKα blocked this connection. Therefore, our findings suggest a mechanism in which an IKKα-NPM axis may use inflammatory signals to suppress centrosome amplification, promote genomic integrity, and prevent tumor progression.

Indexed as

Genomic InstabilitySignal TransductionAnimalsCarcinogenesisCarcinoma, Squamous CellCell Line, TumorCentrosomeCHO CellsCricetinaeCricetulusGenomeHEK293 CellsHumansI-kappa B KinaseInflammationMiceI-kappa B KinaseNPM1 protein, humanNuclear ProteinsNucleophosmin

Identifiers

PMID24290756
PMCPMC4159076
OpenAlexW1966376361

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.